TLR3 and melanoma: In contrast, in melanoma and head and neck SCCs, TLR3 activation is associated with good prognosis and tumor regression, likely because of TLR3 activation of apoptosis-inducing mechanisms (Salaun et al, 2007; Nomi et al, 2010).